Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain
  • Study on the Effects of GV1001 for Patients with Mild to Moderate Alzheimer’s Disease

    Not recruiting

    Investigated drugs:
    Finland France Italy The Netherlands Poland Portugal +1
  • Study of Axi-Cel, Fludarabine Phosphate, and Cyclophosphamide for Patients with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma Ineligible for Stem Cell Transplant

    Not recruiting

    1 1 1
    France
  • Study of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Not Had Chemotherapy

    Not recruiting

    1 1
    Investigated drugs:
    France Spain
  • Study on the Safety and Effects of PTC518 for Patients with Huntington’s Disease

    Not recruiting

    Investigated diseases:
    Investigated drugs:
    Austria France Germany Italy The Netherlands Spain
  • Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +7
  • Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Belgium France Germany Ireland Italy The Netherlands +3
  • Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria France Greece Italy Poland Spain
  • Study on Cannabidiol as Add-on Therapy for Seizures in Patients Aged 1-65 with Tuberous Sclerosis Complex

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Poland
  • Study on Ublituximab and Drug Combination for Patients with Myasthenia Gravis or Relapsing Multiple Sclerosis

    Not recruiting

    1 1 1
    Poland